Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Other Accumulated Expenses (2025)

Coya Therapeutics (COYA) has disclosed Other Accumulated Expenses for 1 consecutive years, with $43139.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses changed N/A to $43139.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43139.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $43139.0 for FY2025, N/A changed from the prior year.
  • Other Accumulated Expenses hit $43139.0 in Q4 2025 for Coya Therapeutics.
  • In the past five years, Other Accumulated Expenses ranged from a high of $43139.0 in Q4 2025 to a low of $43139.0 in Q4 2025.